Connor, Clark & Lunn Investment Management Ltd. - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$106,000
+55.9%
24,595
+49.7%
0.00%
Q3 2020$68,000
+100.0%
16,430
+24.0%
0.00%
Q2 2020$34,000
-73.2%
13,254
-69.9%
0.00%
-100.0%
Q1 2020$127,000
+39.6%
43,966
+84.0%
0.00%0.0%
Q4 2019$91,000
-76.4%
23,900
+75.7%
0.00%
-66.7%
Q4 2015$385,000
+117.5%
13,600
+28.3%
0.00%
+200.0%
Q3 2015$177,000
-38.5%
10,600
-3.6%
0.00%
-66.7%
Q2 2015$288,000
+50.0%
11,0000.0%0.00%
+50.0%
Q1 2015$192,00011,0000.00%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders